Brain tumors are, in my opinion, some of the most important ailments to consider. Glioblastoma is regarded as one of the more serious conditions that the body can show and I do not think that anyone can argue with just how detrimental this can be. This is especially true when you consider that procedures are seen in order to bring this down. That being said, what are immune cells and how can they come into effect for the sake of potential tumor removal in the long term?
According to an article on Medical News Today, it seems as though there are specialized immune cells that have been deactivated in these brain tumors. The University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute looked into these and applied clinical trials to the matter as well. It's not like there aren't treatments, as organizations like Voices against Brain Cancer can attest to. However, with a median survival of only 15 months, the treatments in question are not as effective as they probably should be.
What is the story with these immune cells in the tumors, you may wonder? The report said that they are referred to as microglia, which commonly work to prevent against infection and injury. One can look at these cells as the brain's immune system of sorts and perhaps there is no term better fitting. When it comes to tumors, the formation begins with stem cells. What the immune cells do is detect the cells early and work to eliminate them as quickly as possible.
The report went into detail about a study that would be able to target the immune cells in relation to tumors. One of the more prominent points to consider is the usage of a drug by the name of amphotericin B, which would be put into place for the sake of making microglia active again. It's not like AmpB hasn't been used before; in the past, it worked for the sake of fungal infections against the brain and spine. To say that the results of the study were strong would be an understatement.
With this drug being implemented on a daily basis, the mice used in the study were able to see their tumors halted in terms of progression. This is because the drug in question was able to facilitate their natural defense mechanisms, which means that there is a possibility for this procedure to be tailored for humans as well. I think that this is especially worthy of note when you consider that therapies, in general, have been spotty. I can only hope that this one will prove more worthwhile.
According to an article on Medical News Today, it seems as though there are specialized immune cells that have been deactivated in these brain tumors. The University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute looked into these and applied clinical trials to the matter as well. It's not like there aren't treatments, as organizations like Voices against Brain Cancer can attest to. However, with a median survival of only 15 months, the treatments in question are not as effective as they probably should be.
What is the story with these immune cells in the tumors, you may wonder? The report said that they are referred to as microglia, which commonly work to prevent against infection and injury. One can look at these cells as the brain's immune system of sorts and perhaps there is no term better fitting. When it comes to tumors, the formation begins with stem cells. What the immune cells do is detect the cells early and work to eliminate them as quickly as possible.
The report went into detail about a study that would be able to target the immune cells in relation to tumors. One of the more prominent points to consider is the usage of a drug by the name of amphotericin B, which would be put into place for the sake of making microglia active again. It's not like AmpB hasn't been used before; in the past, it worked for the sake of fungal infections against the brain and spine. To say that the results of the study were strong would be an understatement.
With this drug being implemented on a daily basis, the mice used in the study were able to see their tumors halted in terms of progression. This is because the drug in question was able to facilitate their natural defense mechanisms, which means that there is a possibility for this procedure to be tailored for humans as well. I think that this is especially worthy of note when you consider that therapies, in general, have been spotty. I can only hope that this one will prove more worthwhile.
About the Author:
Contact Voices Against Brain Cancer if you're searching for some additional information about brain tumor research.
No comments:
Post a Comment